Skip to Main Content

Advertisement

Skip Nav Destination

Pembrolizumab Addition Improves Clinical Response in HER2+ Gastric Cancer

Cancer Discov (2022) 12 (2): 289.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal